News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Renjith Vijayakumar Selvarani: An Indian-based startup OLUSIUM is breaking new ground in cancer diagnostics
Photo of Renjith Vijayakumar Selvarani from researchgate.net
Jun 25, 2025, 14:06

Renjith Vijayakumar Selvarani: An Indian-based startup OLUSIUM is breaking new ground in cancer diagnostics

Renjith Vijayakumar Selvarani, Founder, Chairman, Chief Scientific and Technology Officer at OLUSIUM, shared a post on LinkedIn:

“An Indian-based startup OLUSIUM is breaking new ground in cancer diagnostics! 
A highly accurate, early stage, real time, label free, cost effective multi-cancer detection test that can identify asymptomatic cancers and deliver digital pathology results on time. This means:
Faster patient turnaround with real-time insights
– No labels or markers required
– Lower costs for broader access
– Early detection when treatment can be most effective
Pilot and early multicentric validation have shown extremely promising results – and we’re just getting started!
bring better, faster, and more affordable cancer detection to patients everywhere.”

OLUSIUM

More posts featuring Renjith Vijayakumar Selvarani on OncoDaily.

cancer OLUSIUM OncoDaily Oncology Renjith Vijayakumar Selvarani
Special Coverage
Blog
Jun 25, 2025, 14:06
Renjith Vijayakumar Selvarani: An Indian-based startup OLUSIUM is breaking new ground in cancer diagnostics
Insight
Jun 25, 2025, 13:56
Loay Kassem Announced the Launch of "Not Her Journey Alone" Breast Cancer Educational Series with AstraZeneca Egypt
Career
Jun 25, 2025, 13:47
Nitin Yashas Murthy Joins Manipal Hospital Kanakpura Road as Medical Oncologist and Hemato-Oncologist
Blog
Jun 25, 2025, 13:24
Join EIOC on 26th June to Explore Breast Cancer Updates from ASCO 2025
Blog
Jun 25, 2025, 13:02
Andreas Charalambous Highlights MASCC Board Session in Seattle - Strategic Vision for Supportive Care
Science
Jun 25, 2025, 12:45
Elizabeth McKenna: New Studies on KAT6/7 Histone Acetyltransferase as Therapeutic Targets in AML Published in Cancer Discovery
Blog
Jun 25, 2025, 12:26
Despite Improvements in Cancer Care: Stakeholder Policy Forum on Persisting Challenges in Cyprus - ECO
Blog
Jun 25, 2025, 12:09
Apply for AACR James Ewing-Thelma Dunn Award for Outstanding Achievement in Pathology in Cancer Research by June 30
Oncolibrary
Jun 25, 2025, 10:27
The Day After a Nuclear Bomb: Generational Damage and the Silent Cancer Epidemic
Blog
Jun 25, 2025, 10:00
Scientific Advisory Board Members - World Bladder Cancer Patient Coalition
Science
Jun 25, 2025, 09:58
Prerna Mewawalla: Excited to Share our Multicenter Study on Real-world Outcomes of Sequential BCMA Therapies in RRMM After Belantamab
Insight
Jun 25, 2025, 09:52
Shruti Patel: Who Decides Who Decides?